DrugPatentWatch Database Preview
Teva Parenteral Company Profile
What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?
TEVA PARENTERAL has forty-seven approved drugs.
There are six tentative approvals on TEVA PARENTERAL drugs.
Summary for Teva Parenteral
| US Patents: | 0 |
| Tradenames: | 39 |
| Ingredients: | 37 |
| NDAs: | 47 |
| Patent Litigation for Teva Parenteral: | See patent lawsuits for Teva Parenteral |
Drugs and US Patents for Teva Parenteral
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-003 | Dec 21, 1987 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Teva Parenteral | ADRUCIL | fluorouracil | INJECTABLE;INJECTION | 081225-001 | Aug 28, 1991 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 040015-004 | Apr 29, 1993 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | DOPAMINE HYDROCHLORIDE | dopamine hydrochloride | INJECTABLE;INJECTION | 073000-001 | Oct 23, 1991 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 040015-002 | Apr 29, 1993 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 074795-001 | Sep 10, 1996 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teva Parenteral | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 072974-001 | Nov 22, 1991 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Teva Parenteral
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-001 | Approved Prior to Jan 1, 1982 | 3,444,294 | Start Trial |
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-002 | Approved Prior to Jan 1, 1982 | 3,444,294 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
